Frédéric Tewes

1.4k total citations
45 papers, 1.1k citations indexed

About

Frédéric Tewes is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Frédéric Tewes has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 16 papers in Pharmaceutical Science and 10 papers in Molecular Biology. Recurrent topics in Frédéric Tewes's work include Inhalation and Respiratory Drug Delivery (26 papers), Advanced Drug Delivery Systems (13 papers) and Antibiotic Resistance in Bacteria (8 papers). Frédéric Tewes is often cited by papers focused on Inhalation and Respiratory Drug Delivery (26 papers), Advanced Drug Delivery Systems (13 papers) and Antibiotic Resistance in Bacteria (8 papers). Frédéric Tewes collaborates with scholars based in France, Ireland and Spain. Frédéric Tewes's co-authors include Anne Marie Healy, Frank Boury, Carsten Ehrhardt, Julien Brillault, William Couet, Jean‐Christophe Olivier, Oliviero L. Gobbo, Lidia Tajber, Pierre Dubois and Igor Chourpa and has published in prestigious journals such as The Journal of Physical Chemistry B, Langmuir and Scientific Reports.

In The Last Decade

Frédéric Tewes

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Tewes France 22 453 375 231 202 182 45 1.1k
Cynthia Bosquillon United Kingdom 21 928 2.0× 496 1.3× 176 0.8× 195 1.0× 319 1.8× 41 1.6k
A. Ben-Jebria United States 10 956 2.1× 481 1.3× 112 0.5× 209 1.0× 184 1.0× 18 1.4k
Raimar Löebenberg Canada 14 230 0.5× 555 1.5× 215 0.9× 162 0.8× 207 1.1× 33 1.4k
Shirzad Azarmi Iran 18 551 1.2× 769 2.1× 331 1.4× 228 1.1× 251 1.4× 30 1.6k
Margareth Marques United States 8 145 0.3× 553 1.5× 203 0.9× 175 0.9× 157 0.9× 40 1.3k
Pratibhash Chattopadhyay United States 10 535 1.2× 530 1.4× 138 0.6× 498 2.5× 149 0.8× 10 1.5k
Qiaoyu Liu China 21 313 0.7× 332 0.9× 132 0.6× 171 0.8× 358 2.0× 77 1.3k
Lea Ann Dailey United Kingdom 28 872 1.9× 546 1.5× 456 2.0× 565 2.8× 622 3.4× 95 2.5k
Giovanni Caponetti Italy 7 680 1.5× 385 1.0× 122 0.5× 179 0.9× 159 0.9× 10 1.1k
Christian A. Ruge Germany 13 525 1.2× 188 0.5× 218 0.9× 178 0.9× 181 1.0× 15 925

Countries citing papers authored by Frédéric Tewes

Since Specialization
Citations

This map shows the geographic impact of Frédéric Tewes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Tewes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Tewes more than expected).

Fields of papers citing papers by Frédéric Tewes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Tewes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Tewes. The network helps show where Frédéric Tewes may publish in the future.

Co-authorship network of co-authors of Frédéric Tewes

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Tewes. A scholar is included among the top collaborators of Frédéric Tewes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Tewes. Frédéric Tewes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tewes, Frédéric, et al.. (2025). Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases. Drug Delivery and Translational Research. 15(9). 2967–2993. 4 indexed citations
2.
3.
Buyck, Julien M., Sandrine Marchand, M. Marcotte, et al.. (2024). (E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii. International Journal of Pharmaceutics. 667(Pt A). 124907–124907. 1 indexed citations
4.
Marchand, Sandrine, et al.. (2024). Assessment of inhaled cationic antibiotics in an in vitro model of Pseudomonas aeruginosa lung biofilm. Microbial Pathogenesis. 197. 107020–107020. 3 indexed citations
5.
Aucher, Willy, Anne Mercier, Frédéric Tewes, et al.. (2024). Insights into betulinic acid as a promising molecule to fight the interkingdom biofilm Staphylococcus aureus–Candida albicans. International Journal of Antimicrobial Agents. 63(6). 107166–107166. 11 indexed citations
6.
Pérez, Marta, Víctor Sebastián, Manuel Arruebo, et al.. (2023). Real-time in vivo monitoring of the antimicrobial action of combination therapies in the management of infected topical wounds. International Journal of Pharmaceutics. 646. 123502–123502. 2 indexed citations
7.
Tewes, Frédéric, et al.. (2023). PK-PD Evaluation of Inhaled Microparticles loaded with Ciprofloxacin-Copper complex in a Rat Model of Chronic Pseudomonas aeruginosa Lung Infection.. International Journal of Pharmaceutics X. 5. 100178–100178. 3 indexed citations
8.
Marchand, Sandrine, et al.. (2022). Improved In Vitro Anti-Mucorales Activity and Cytotoxicity of Amphotericin B with a Pegylated Surfactant. Journal of Fungi. 8(2). 121–121. 3 indexed citations
9.
Tewes, Frédéric, et al.. (2022). Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections. Pharmaceutics. 14(3). 641–641. 14 indexed citations
10.
Buyck, Julien M., et al.. (2021). Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. coli MCR-1 to Colistin. Pharmaceutics. 13(11). 1849–1849. 8 indexed citations
11.
Brillault, Julien & Frédéric Tewes. (2020). Control of the Lung Residence Time of Highly Permeable Molecules after Nebulization: Example of the Fluoroquinolones. Pharmaceutics. 12(4). 387–387. 22 indexed citations
12.
Tewes, Frédéric, Julien Brillault, Nicolas Grégoire, et al.. (2020). Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery. Pharmaceutics. 12(6). 557–557. 7 indexed citations
13.
Tewes, Frédéric, et al.. (2019). Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms. AAPS PharmSciTech. 20(5). 205–205. 12 indexed citations
14.
Zhang, Hairui, et al.. (2018). PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro. Molecular Pharmaceutics. 15(4). 1643–1652. 36 indexed citations
15.
Gaspar, Marisa C., João Sousa, Alberto A. C. C. Pais, et al.. (2015). Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy. European Journal of Pharmaceutics and Biopharmaceutics. 96. 65–75. 42 indexed citations
16.
Tewes, Frédéric, Krzysztof J. Paluch, Lidia Tajber, et al.. (2013). Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 604–613. 29 indexed citations
17.
Gobbo, Oliviero L., et al.. (2013). Encapsulation into PEG-Liposomes Does Not Improve the Bioavailability of Pulmonary Delivered Salmon Calcitonin. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(1). 1–11. 25 indexed citations
18.
Tewes, Frédéric, Carsten Ehrhardt, & Anne Marie Healy. (2013). Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung. European Journal of Pharmaceutics and Biopharmaceutics. 86(1). 98–104. 37 indexed citations
19.
Tewes, Frédéric, Lidia Tajber, Owen I. Corrigan, Carsten Ehrhardt, & Anne Marie Healy. (2010). Development and characterisation of soluble polymeric particles for pulmonary peptide delivery. European Journal of Pharmaceutical Sciences. 41(2). 337–352. 32 indexed citations
20.
Tewes, Frédéric, Emilie Munnier, S. Cohen-Jonathan, et al.. (2007). Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. European Journal of Pharmaceutics and Biopharmaceutics. 66(3). 488–492. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia Bosquillon Breakdown of academic impact, for papers by A. Ben-Jebria Breakdown of academic impact, for papers by Raimar Löebenberg Breakdown of academic impact, for papers by Shirzad Azarmi Breakdown of academic impact, for papers by Margareth Marques Breakdown of academic impact, for papers by Pratibhash Chattopadhyay Breakdown of academic impact, for papers by Qiaoyu Liu Breakdown of academic impact, for papers by Lea Ann Dailey Breakdown of academic impact, for papers by Giovanni Caponetti Breakdown of academic impact, for papers by Christian A. Ruge
Rankless by CCL
2026